WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced a partnershi

Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.59% on an annualized basis

Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising

MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Ba

Analysts upgraded SFNC, OBIO, and more.

Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and i

UBS analyst Doug Schenkel upgrades Waters (NYSE:WAT) from Neutral to Buy and raises the price tar

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Benjamin Edwards Inc. lifted its holdings in shares of Waters Corporation (NYSE: WAT) by 72.5% in th

Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.82% on an annualized basis

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Top Wall Street analysts upgraded BWX Technologies, The Macerich Company, and Waters Corporation. Ch

Piper Sandler analyst David Westenberg upgrades Waters (NYSE:WAT) from Neutral to Overweight and

WEST CHESTER, Ohio--(BUSINESS WIRE)--LetsGetChecked now offers the most comprehensive FDA-cleared at

MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Bat

Bank of Nova Scotia cut its stake in shares of Waters Corporation (NYSE: WAT) by 27.3% in the second

Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the se

Assetmark Inc. lowered its holdings in Waters Corporation (NYSE: WAT) by 56.5% in the second quarter

Citigroup analyst Joanne Wuensch maintains Waters (NYSE:WAT) with a Buy and raises the price targ

Dudley and Shanley Inc. raised its holdings in Waters Corporation (NYSE: WAT) by 101.3% in the secon

Waters Corporation (NYSE: WAT - Get Free Report) Director Christopher Kuebler sold 3,626 shares of W

Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic consta

Empowered Funds LLC lifted its stake in Waters Corporation (NYSE: WAT) by 431.0% in the first quarte

TD Cowen analyst Dan Brennan upgrades Waters (NYSE:WAT) from Hold to Buy and raises the price tar

WAT tops Q2 estimates, raises its 2026 outlook and posts broad-based growth across organic and acqui

RBC Capital analyst Dan Leonard maintains Waters (NYSE:WAT) with a Outperform and raises the pric

Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a Outperform and raises t

Wells Fargo analyst Evan Stampler maintains Waters (NYSE:WAT) with a Equal-Weight and raises the

Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price

Cetera Investment Advisers increased its stake in Waters Corporation (NYSE: WAT) by 121.0% during th

Waters Corporation (WAT) Q2 2026 Earnings Call Transcript

Waters (NYSE:WAT) is looking for Q3 Adj EPS of $3.95-$4.05 vs $3.99 analyst estimate. sees sales of

Waters (NYSE:WAT) raises FY2026 Adj EPS guidance from $14.40-$14.60 to $14.45-$14.65 vs $14.51 analy

Waters (NYSE:WAT) reported quarterly earnings of $3.05 per share which beat the analyst consensus es

Goldman Sachs analyst Patrick Donnelly maintains Waters (NYSE:WAT) with a Buy and raises the pric

Morgan Stanley analyst Kallum Titchmarsh maintains Waters (NYSE:WAT) with a Equal-Weight and rais

RBC Capital analyst Dan Leonard initiates coverage on Waters (NYSE:WAT) with a Outperform rating

Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a Outperform and raises t

Piper Sandler analyst David Westenberg initiates coverage on Waters (NYSE:WAT) with a Neutral rat

FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader acce

B of A Securities analyst Derik De Bruin maintains Waters (NYSE:WAT) with a Neutral and raises th

Wolfe Research analyst Mike Polark assumes Waters (NYSE:WAT) with a Outperform rating and announc

Wells Fargo analyst Brandon Couillard maintains Waters (NYSE:WAT) with a Equal-Weight and raises

Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price

JP Morgan analyst Casey Woodring maintains Waters (NYSE:WAT) with a Neutral and raises the price

TD Cowen analyst Dan Brennan maintains Waters (NYSE:WAT) with a Hold and raises the price target

The Nasdaq 100 surged past 28,000 during Tuesday morning trading, setting a fresh record as AI-drive